Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 Next >
5 things to know before the stock market opens
Tags Nasdaq Inc Walt Disney Co 5 Things to Know
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
Tags Europe: Top News And Analysis US Top News and Analysis Europe News
From CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Tags Eli Lilly and Co Health care industry Novo Nordisk A/S
From CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Europe Markets Zealand Pharma A/S Pharmaceuticals
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Social issues Health & Science Labor economy
From CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Tags Pharmaceuticals Business Business News
From CNBC.com News
European stocks set for muted open after European Central Bank cut
Tags World Economy Novo Nordisk A/S Prices
From CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
Tags Employee benefits Weight loss diets Employee healthcare benefits
From CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
Tags Eli Lilly and Co Health care industry Novo Nordisk A/S
From CNBC.com News
Cramer's Lightning Round: Apple is a buy
Tags Novo Nordisk A/S Bristol/Myers Squibb Co Palantir Technologies Inc
From CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
Tags Pharmaceuticals stocks Personal investing
From CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
Tags Breaking News: Technology Hims & Hers Health Inc Health & Science
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
Tags Health & Science Uber Technologies Inc Novo Nordisk A/S
From CNBC.com News
AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines
Tags Health care industry Business Europe Markets
From CNBC.com News
Hims & Hers Health adds compounded GLP-1 injections to weight loss program
Tags Technology Internet Enterprise
From CNBC.com News
Roche says weight loss drug shows promising results in early trial
Tags Business News Health & Science Biotechnology
From CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
Tags Healthy Returns Health care industry Science
From CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
Tags US: News Companies Social issues
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
Tags Apple Inc Healthy Returns Eli Lilly and Co
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Tags US: News Companies AstraZeneca PLC
From CNBC.com News
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Amgen Inc
From CNBC.com News
Amgen scraps experimental weight loss pill, moves forward with injection
Tags Earnings Health care industry Eli Lilly and Co
From CNBC.com News
Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double
Tags Earnings Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
Tags Amphastar Pharmaceuticals Inc Teva Pharmaceutical Industries Ltd Business News
From CNBC.com News
Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.
Tags Policy Congress Health care industry
From CNBC.com News
More than 3 million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease risks, study says
Tags Breaking news Business Pharmaceuticals
From CNBC.com News
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
Tags Breaking news Morgan Stanley Health & Science
From CNBC.com News
Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says
Tags Biotechnology US: News Companies
From CNBC.com News
Eli Lilly’s Zepbound shows promise as a sleep apnea treatment in late-stage trials
Tags Health & Science Business News US: News
From CNBC.com News
EU probe of weight loss and diabetes drugs like Wegovy, Ozempic finds no link to suicidal thoughts
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health care industry
From CNBC.com News
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.